XML 174 R56.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock-Based Compensation Plans (All Registrants) (Tables)
12 Months Ended
Dec. 31, 2018
Common Stock [Abstract]  
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]
The following tables present the stock-based compensation expense included in Exelon's and PHI’s Consolidated Statements of Operations and Comprehensive Income for the years ended December 31, 2018, 2017 and 2016 and PHI's predecessor period January 1, 2016 to March 23, 2016:
Exelon
Year Ended
December 31,
Components of Stock-Based Compensation Expense
2018
 
2017
 
2016(a)
Performance share awards
$
143

 
$
107

 
$
93

Restricted stock units
57

 
77

 
75

Stock options

 

 

Other stock-based awards
8

 
7

 
7

Total stock-based compensation expense included in operating and maintenance expense
208

 
191

 
175

Income tax benefit
(54
)
 
(74
)
 
(68
)
Total after-tax stock-based compensation expense
$
154

 
$
117

 
$
107


__________
(a)
2016 amounts include expense related to stock-based compensation granted to eligible PHI employees since the merger date of March 23, 2016.
PHI
 
Predecessor
 
January 1 to March 23,
Components of Stock-Based Compensation Expense
2016
Time-based restricted stock units
$
2

Performance-based restricted stock units
1

Time-based restricted stock awards

Total stock-based compensation expense included in operating and
maintenance expense
3

Income tax benefit
(1
)
Total after-tax stock-based compensation expense
$
2

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]
The following tables present the Registrants' stock-based compensation expense (pre-tax) for the years ended December 31, 2018, 2017 and 2016, as well as for the PHI predecessor period January 1, 2016 to March 23, 2016:
 
Year Ended
December 31,
Subsidiaries
2018
 
2017
 
2016
Exelon
$
208

 
$
191

 
$
175

Generation
77

 
88

 
78

ComEd
8

 
7

 
8

PECO
5

 
3

 
3

BGE
3

 
1

 
1

BSC(a)
111

 
88

 
81

PHI Successor(b)(c)
4

 
4

 
4

 
Predecessor
 
January 1 to
March 23,
 
2016
PHI
$
3

__________
(a)
These amounts primarily represent amounts billed to Exelon’s subsidiaries through intercompany allocations. These amounts are not included in the Generation, ComEd, PECO, BGE or PHI amounts above.
(b)
Pepco's, DPL's and ACE's stock-based compensation expense for the years ended December 31, 2018 and 2017 was not material.
(c)
These amounts primarily represent amounts billed to PHI’s subsidiaries through PHISCO intercompany allocations.
Stock Based Compensation Tax Benefit
The following tables present information regarding Exelon’s tax benefits for the years ended December 31, 2018, 2017 and 2016.
Exelon
Year Ended December 31,
 
2018
 
2017
 
2016
Realized tax benefit when exercised/distributed:
 
 
 
 
 
Restricted stock units
28

 
35

 
27

Performance share awards
16

 
29

 
18

Schedule of Share-based Compensation, Stock Options, Activity
The following table presents information with respect to stock option activity for the year ended December 31, 2018:
 
Shares
 
Weighted
Average
Exercise
Price
(per share)
 
Weighted
Average
Remaining
Contractual
Life
(years)
 
Aggregate
Intrinsic
Value
Balance of shares outstanding at December 31, 2017
6,723,611

 
$
47.69

 
2.65
 
$
7

Options exercised
(1,522,952
)
 
36.54

 
 
 
 
Options forfeited

 

 
 
 
 
Options expired
(1,173,007
)
 
74.99

 
 
 
 
Balance of shares outstanding at December 31, 2018
4,027,652

 
$
43.95

 
2.90
 
$
14

Exercisable at December 31, 2018 (a)
4,027,652

 
$
43.95

 
2.90
 
$
14

__________
(a)
Includes stock options issued to retirement eligible employees.
Stock Options Exercised
The following table summarizes additional information regarding stock options exercised for the years ended December 31, 2018, 2017 and 2016:
 
Year Ended
December 31,
 
2018
 
2017
 
2016
Intrinsic value(a)
$
12

 
$
15

 
$
11

Cash received for exercise price
56

 
107

 
19

__________
(a)
The difference between the market value on the date of exercise and the option exercise price.
Schedule of Nonvested Restricted Stock Units Activity
The following table summarizes Exelon’s nonvested restricted stock unit activity for the year ended December 31, 2018:
Exelon
 
Shares
 
Weighted Average
Grant Date Fair
Value (per share)
Nonvested at December 31, 2017(a)
3,389,503

 
$
32.24

Granted
1,321,988

 
38.60

Vested
(1,845,300
)
 
32.03

Forfeited
(65,046
)
 
32.96

Undistributed vested awards (b)
(507,804
)
 
36.76

Nonvested at December 31, 2018(a)
2,293,341

 
$
35.06

__________
(a)
Excludes 1,131,487 and 1,488,383 of restricted stock units issued to retirement-eligible employees as of December 31, 2018 and 2017, respectively, as they are fully vested.
(b)
Represents restricted stock units that vested but were not distributed to retirement-eligible employees during 2018.
Schedule of Nonvested Performance-based Units Activity
The following table summarizes Exelon’s nonvested performance share awards activity for the year ended December 31, 2018:
Exelon 
 
Shares
 
Weighted Average
Grant Date Fair
Value (per share)
Nonvested at December 31, 2017(a)
2,956,966

 
$
32.65

Granted
1,637,542

 
38.15

Change in performance
1,348,029

 
30.66

Vested
(848,574
)
 
36.26

Forfeited
(50,467
)
 
36.24

Undistributed vested awards (b)
(1,640,268
)
 
33.38

Nonvested at December 31, 2018(a)
3,403,228

 
$
33.13

__________
(a)
Excludes 3,586,259 and 2,723,440 of performance share awards issued to retirement-eligible employees as of December 31, 2018 and 2017, respectively, as they are fully vested.
(b)
Represents performance share awards that vested but were not distributed to retirement-eligible employees during 2018.
The following table summarizes the weighted average grant date fair value and the fair value of performance share awards granted and settled for the years ended December 31, 2018, 2017 and 2016:
 
Year Ended
December 31,
 
2018(a)
 
2017
 
2016
Weighted average grant date fair value (per share)
$
38.15

 
$
35.00

 
$
28.85

Fair value of performance shares settled
61

 
72

 
45

Fair value of performance shares settled in cash
49

 
56

 
28

__________
(a)
As of December 31, 2018, $33 million of total unrecognized compensation costs related to nonvested performance shares are expected to be recognized over the remaining weighted-average period of 1.7 years.
Not Settled Performance Share Awards Balance Sheet Presentation
The following table presents the balance sheet classification of obligations related to outstanding performance share awards not yet settled:
 
December 31,
 
2018
 
2017
Current liabilities(a)
$
135

 
$
57

Deferred credits and other liabilities(b)
109

 
100

Common stock
26

 
26

Total
$
270

 
$
183

__________
(a)
Represents the current liability related to performance share awards expected to be settled in cash.
(b)
Represents the long-term liability related to performance share awards expected to be settled in cash.